View these LCRP funding opportunities

Applications submitted to the FY23 LCRP must address one or more of the following Areas of Emphasis:

• Biology and Etiology
  • Understand the molecular mechanisms of initiation and progression to lung cancer.
  • Understand contributors to lung cancer development other than tobacco.
• Prevention
  • Identify innovative strategies for prevention of the occurrence of lung cancer(s) or subsequent primaries.
  • Identify innovative strategies for the prevention of recurrence or metastases from lung cancer.
• Detection, Diagnosis, and Surveillance
  • Improve approaches to screening and early detection of lung cancer.
  • Identify strategies for prompt detection and/or characterization of progressive disease.
• Treatment and Prognosis
  • Identify innovative strategies for the treatment of lung cancer, including overcoming resistance.
  • Develop or optimize biomarkers to assist with therapeutic decision-making.
  • Enhance the treatment and understanding of brain metastases in lung cancer.
• Health Outcomes and Survivorship
  • Identify and understand the long-term and cumulative effects of lung cancer and its treatment(s) with respect to the impact of comorbidities on patient care and also, more broadly, in respect to their effects on patients and their quality of life including, but not limited to, physiological, psychosocial, cognitive, and financial effects.
• Disparities
  • Advance equity and reduce lung cancer disparities among underserved and underrepresented populations.

Relevance to Military Health:  The LCRP seeks to support research that is relevant to the healthcare needs of military Service Members, Veterans, and their families. Relevance to military health will be considered in determining relevance to the mission of the Defense Health Program and FY23 LCRP during programmatic review. Investigators are strongly encouraged to consider the following characteristics as examples of how a project may demonstrate relevance to military health:

• Use of military or Veteran populations, biospecimens, data/databases, or programs in the proposed research.
• Collaboration with DOD or Department of Veterans Affairs investigators.
• Explanation of how the project addresses an aspect of lung cancer that has a direct relevance or is unique to the military, Veterans, other military health system beneficiaries, or family readiness of Service Members, including environmental exposures other than tobacco.